FDA Drug recall D-0092-2021
Willa Clear Skin (Salicylic Acid 2%), 4.2 fl oz 124ml tubes, WBC Group LLC, Dist
- FDA Drug
- Class II
- terminated
- Published 2020-11-25
On 2020-11-25 the FDA classified a Class II recall of Willa Clear Skin (Salicylic Acid 2%), 4.2 fl oz 124ml tubes, WBC Group LLC, Dist by Milbar Laboratories, citing GMP Deviations.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0092-2021 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2020-10-09 |
| Published | 2020-11-25 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Milbar Laboratories |
| Distribution | US |
Product
Willa Clear Skin (Salicylic Acid 2%), 4.2 fl oz 124ml tubes, WBC Group LLC, Dist. Chandler, AZ 85226
Reason
GMP Deviations
Identifiers
| code_info | Lot #: DW827-4, Exp. Date Mar-22 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0092-2021%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.